Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 85 (RPL21P85)

Target
RPL21P85
Molecular classification
Other (Pseudogene; specifically, processed ribosomal protein pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 85 (RPL21P85) is a processed pseudogene in the human genome, originating from the gene encoding ribosomal protein L21[1][11]. Processed pseudogenes arise when reverse-transcribed mRNA is inserted into the genome, typically resulting in nonfunctional sequences due to lack of regulatory elements or disabling mutations[2]. RPL21P85 does not produce a protein and is not known to play a regulatory or functional role. Its presence is typical of ribosomal protein genes, which often have many pseudogenes dispersed through the genome due to their high expression and retrotranspositional activity[2][1][7]. There is no evidence that RPL21P85 acts as a receptor, enzyme, transporter, or other druggable target[1][3][11]. The associated functional gene, ribosomal protein L21 (RPL21), is implicated in ribosome assembly and several diseases, but the pseudogene itself has no known direct association with pathology or therapeutics[9][11][7].\n\nKey clarifications:\n- RPL21P85 is not a receptor, enzyme, transporter, or functional protein[1][11].\n- It is not considered a drug target and has no known biological, disease, or biomarker relevance[1][11].\n- The functional gene RPL21 (not the pseudogene) is related to ribosomal protein function and associated with certain genetic diseases, but this does not apply to RPL21P85[5][9].

Other names
RPL21_33_996RPL21P85[4][11]

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 85 (RPL21P85).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 85 (RPL21P85).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call